Skip to content
中文产业新闻评分65Chinese source

君赛生物诺吉仑赛注射液拟纳入CDE优先审评,治疗经治转移性黑色素瘤

国内首个TIL疗法拟纳入优先审评

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.